Status:
TERMINATED
Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes
Lead Sponsor:
Stanford University
Conditions:
Type1diabetes
Eligibility:
All Genders
13-19 years
Phase:
NA
Brief Summary
To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques,...
Detailed Description
The investigators will use an automated data integration system to monitor hours per week the CGM is worn and target interventions/troubleshooting techniques as needed. The investigators will use gami...
Eligibility Criteria
Inclusion
- type 1 diabetes for more than 6 months
- on insulin pump or multiple daily injections without plans to change modality in next 6 months
- insured by CCS or Medi-Cal
- receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics
- English or Spanish-speaking
Exclusion
- major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy
- current oral glucocorticoid use
- prior use of a CGM system
- hemoglobin A1C \<7.5% or \>12%
- no wireless internet access
Key Trial Info
Start Date :
May 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03297762
Start Date
May 7 2018
End Date
June 1 2019
Last Update
April 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Children's
Stanford, California, United States, 94305